Why would any savvy investment teams or even big pharma want to work with this team when they have done nothing but lost shareholder wealth consistently over the last 15 years. All they do is come up with excuses and victim mindset rather than executing relentlessly.
The proof is right in front of us. 5 years since data lock and no reimbursement evidence submission even in a tiny and most supportive jurisdiction they submitted their application to. No FDA BLA guidance either.
Just wait for new set of excuses and dangling of carrots! Another 70-90% downside is loading.